Treatment of recalcitrant pustular psoriasis with infliximab: Effective reduction of chemokine expression

British Journal of Dermatology

Volumn 150, Issue 5, 2004, Pages 1009-1012

  Benoit, S ^a   Toksoy, A ^a   Brocker E B ^a   Gillitzer, R ^a   Goebeler, M ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Growth related oncogene ; Infliximab; Interleukin 8; Monocyte chemoattractant protein 1; Pustular psoriasis; Tumour necrosis factor

Indexed keywords

CHEMOKINE; ETRETIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GROWTH RELATED ONCOGENE ALPHA PROTEIN; INFLIXIMAB; INTERLEUKIN 8; METHOTREXATE; MONOCYTE CHEMOTACTIC PROTEIN 1; STEROID; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; DERMATOLOGICAL AGENT; MONOCLONAL ANTIBODY;

ADULT; ARTICLE; CASE REPORT; DISEASE CLASSIFICATION; DOSE RESPONSE; DOWN REGULATION; HUMAN; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PUSTULAR PSORIASIS; DRUG ANTAGONISM; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; PSORIASIS; SKIN;

ANTIBODIES, MONOCLONAL; CHEMOKINES; DERMATOLOGIC AGENTS; HUMANS; MALE; MIDDLE AGED; PSORIASIS; SKIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 3042703125     PISSN: 00070963     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2004.05960.x     Document Type: Article

References (10)

1. Lebwohl M. Psoriasis. Lancet 2003; 361: 1197-204.
2. Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agents. J Am Acad Dermatol 2002; 46: 1-23.
3. Sandborn WJ, Hanauer SB. Infliximab in the treatment of Crohn's disease: a user's guide for clinicians. Am J Gastroenterol 2002; 97: 2962-72.
4. Gillitzer R, Berger R, Mielke V et al. Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 1991; 97: 73-9.
5. Gillitzer R, Wolff K, Tong D et al. MCP-1 mRNA expression in basal keratinocytes of psoriatic lesions. J Invest Dermatol 1993; 101: 127-31.
6. Gillitzer R, Ritter U, Spandau U et al. Differential expression of Groα and IL-8 mRNA in psoriasis: a model for neutrophil migration and accumulation in vivo. J Invest Dermatol 1996; 107: 778-82.
7. Goebeler M, Toksoy A, Spandau U et al. The C-X-C chemokine Mig is highly expressed in the papillae of psoriatic lesions. J Pathol 1998; 184: 89-95.
8. Newland MR, Weinstein A, Kerdel F. Rapid response to inflximab in severe pustular psoriasis, von Zumbusch type. Int J Dermatol 2002; 41: 449-52.
9. Elewski BE. Infliximab for the treatment of severe pustular psoriasis. J Am Acad Dermatol 2002; 47: 796-7.
10. Terui T, Ozawa M, Tagami H. Role of neutrophils in induction of acute inflammation in T-cell-mediated immune dermatosis, psoriasis: a neutrophil-associated inflammation-boosting loop. Exp Dermatol 2000; 9: 1-10.